翰宇药业：与三生蔓迪签署司美格鲁肽注射液委托生产和供应协议等

Core Viewpoint - Han Yu Pharmaceutical (300199) has signed a cooperation agreement with Zhejiang San Sheng Man Di Pharmaceutical Co., Ltd. regarding the production and supply of Semaglutide injection for weight loss indications, which is currently in the Phase III clinical trial stage [1] Group 1 - The clinical trial for Semaglutide injection has completed the enrollment of all participants and has entered the stable dosing period [1] - To clarify production and supply matters post-approval, the company has signed several agreements including the Production and Supply Agreement and the Quality Agreement for Drug Production [1]